Skip to main content

Genome Designs Partners with SciDM to Improve its Genome Annotation Pipeline

Premium

Genome Designs said this week that it has formed a partnership with SciDM Group, a bioinformatics tools developer.

Under the terms of the agreement, the company will use SciDM’s database engine, transcriptomics data processing pipeline, and high-throughput sequence comparison technology to augment its genome annotation pipelines and to boost its custom software development projects.

SciDM's database management system, called SciDM Data Manager, is an object-relational database engine that’s optimized to deal with large volumes of data. SciDM said the system operates "thousands of times" faster than conventional database engines when used on bioinformatics tasks like sequence assembly and clustering.

Genome Designs opened its doors in January and provides manual genome annotation services based on its internal analysis pipeline (BI 2/10/2012).

Natalia Alexandrova, CEO of Genome Designs, said in a statement this week that potential clients of the company’s services have also been demanding “custom software tools” as well.

Creating bespoke software is “beyond our scope,” she said. However, “our partnership with SciDM will allow us to shorten development cycles and deliver robust systems without changing the focus of the company.”

SciDM Group describes itself as "an informal non-commercial association of enthusiastic computational biologists and software engineers." Most of its products are open source.

Denis Kaznadzey, who heads SciDM Group, said that although SciDM's tools are free and available for download from public repositories, “they require integration with the client’s system.”

“Our partnership with Genome Designs goes beyond just another vendor-client relationship: they are planning to provide installation and integration services for our products,” he said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.